HOPE

Aggreko Named the Official Military Appreciation Partner of THE CJ CUP Byron Nelson on PGA TOUR

Retrieved on: 
Tuesday, April 2, 2024
Temperature, Ryder Cup, HOPE, Veteran, Heat, Official, Military personnel, Workforce, SCD, TPC Craig Ranch, PGA, Golf, Tourism

Aggreko is working with the Salesmanship Club of Dallas (SCD) , which hosts THE CJ CUP Byron Nelson , to sponsor the prestigious golf tournament as the Official Military Appreciation Partner.

Key Points: 
  • Aggreko is working with the Salesmanship Club of Dallas (SCD) , which hosts THE CJ CUP Byron Nelson , to sponsor the prestigious golf tournament as the Official Military Appreciation Partner.
  • As the Military Partner, Aggeko’s support will enable all active duty, reserve, retired, and veteran military personnel, as well as national guard, to receive two complimentary tickets per day to THE CJ CUP Byron Nelson.
  • Military attendees of THE CJ CUP Byron Nelson will also be able to enjoy the Military Outpost, a dedicated hospitality tent located at the 7th tee.
  • Members of the military can visit the tournament’s website to register for their complimentary tickets to THE CJ CUP Byron Nelson.

Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update

Retrieved on: 
Wednesday, March 27, 2024
Research, Investigational device exemption, Orchestra, HOPE, Partnership, Physician, Patient, Calibration, ISR, Medtronic, Beat (music), Insurance, Heart failure, CNT, Safety, SAB, Hypertension, PMDA, FDA, Pharmaceutical industry

Globally, the treatment of coronary in-stent restenosis and other challenging artery disease indications is rapidly shifting toward drug-coated balloons.

Key Points: 
  • Globally, the treatment of coronary in-stent restenosis and other challenging artery disease indications is rapidly shifting toward drug-coated balloons.
  • Financial Results for the Year Ended December 31, 2023
    Cash and cash equivalents and marketable securities totaled $87.6 million as of December 31, 2023.
  • Net loss for 2023 was $49.1 million, or ($1.48) per share, compared with a net loss of $33.6 million, or ($2.24) per share, for 2022.
  • Net loss for the year-ended 2023 included non-cash stock-based compensation expense of $7.6 million, compared with $3.4 million for the same period in 2022.

Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors

Retrieved on: 
Tuesday, March 26, 2024
HOPE, Orchestra, Environment, CFO, Siemens Healthineers, Partnership, Patient, Knowledge, Medtronic, Senior, Marketing, Research and development, SAB, Division, Management

Mr. Pacitti is currently the President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers.

Key Points: 
  • Mr. Pacitti is currently the President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers.
  • Prior to joining Siemens Healthineers, he was Division Vice President of U.S. Commercial Operations, Sales, and Marketing at Abbott Vascular, overseeing the company’s business in North America.
  • “It’s an honor to welcome Dave to the Orchestra BioMed Board where we expect to benefit from his wealth of experience in driving the adoption of transformational device therapies and procedural imaging modalities,” said David Hochman, chairman, chief executive officer and founder of Orchestra BioMed.
  • I look forward to contributing my perspective to help Orchestra BioMed realize the full potential of its cardiovascular pipeline, strategic partnerships and differentiated business model.”

KeyBank Affirms Commitment to Accessible and Affordable Pathways to Homeownership

Retrieved on: 
Monday, April 8, 2024
HOPE, Education, KeyBank, Investment, National Association, Marketing, Operation, Real estate

CLEVELAND, April 8, 2024 /PRNewswire/ -- As part of its commitment to helping clients on their individual financial journeys, KeyBank (NYSE:KEY) continues to offer resources and education for those seeking to achieve the dream of homeownership.

Key Points: 
  • "We recognize that the homebuying process can feel daunting and we are committed to helping our clients achieve their financial goals," said Dale Baker, President of KeyBank Home Lending.
  • "KeyBank continues to invest in resources, programs and community partnerships to help clients understand their unique financial pictures, address the barriers to homeownership, and improve their overall financial resiliency."
  • To this end, KeyBank committed more than $1 million in 2023 to homebuyer education and other community support.
  • "At KeyBank, we believe in turning aspirations into achievable milestones," said Rachael Sampson, KeyBank's Head of Community Banking for the Consumer Bank.

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, March 21, 2024
Research, SAFE, Growth, HOPE, CE, Patient, PMR, ACTION, UKCA, Hydrocephalus, ECMO, News, MDR, Pediatrics, Malnutrition, Nursing care plan, Marketing, FDA, Video game

Revenues for the fourth quarter of 2023 were $2.69 million, up 89%, compared to $1.42 million in the fourth quarter of 2022.

Key Points: 
  • Revenues for the fourth quarter of 2023 were $2.69 million, up 89%, compared to $1.42 million in the fourth quarter of 2022.
  • Gross margin for the fourth quarter of 2023 was $1.03 million, compared to $0.30 million in the fourth quarter of 2022.
  • Research and development expenses for the fourth quarter of 2023 were $5.96 million, compared to $5.22 million in the fourth quarter of 2022.
  • Sales, marketing, general, and administrative expenses for the fourth quarter of 2023 were $6.70 million, compared to $8.71 million in the fourth quarter of 2022.

Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting

Retrieved on: 
Wednesday, March 13, 2024
Blood pressure, CRT, Investigational device exemption, HOPE, Patient, Inflammation, Stroke, Gold, Restenosis, ISR, Medtronic, Beat (music), Trial of the century, Virtue, Sirolimus, Stent, Safety, Pharmacokinetics, SAB, Hypertension, Molecular mass, Food, Medical device

A second presentation featured recently reported clinical data on atrioventricular interval modulation (“AVIM”) therapy (also known as BackBeat CNT), an investigational therapy delivered via standard dual-chamber pacemakers designed to immediately, substantially and persistently lower blood pressure.

Key Points: 
  • A second presentation featured recently reported clinical data on atrioventricular interval modulation (“AVIM”) therapy (also known as BackBeat CNT), an investigational therapy delivered via standard dual-chamber pacemakers designed to immediately, substantially and persistently lower blood pressure.
  • The AVIM presentation also outlined the design of the currently enrolling BACKBEAT global pivotal study evaluating AVIM therapy in hypertensive pacemaker patients in collaboration with Medtronic.
  • Specifically, the presented PK data showed that:
    Molecular weight of Sostenocel remained unchanged prior to elimination, showing no evidence of in-vivo degradation.
  • AVIM therapy demonstrated:
    Consistent favorable hemodynamic effects using both conduction system, as well as traditional right ventricular lead placements.

The Promise Homes Company Secures Credit Facility from Leading Global Money Center Bank

Retrieved on: 
Thursday, April 4, 2024
Finance, Banking, Professional Services, Residential Building & Real Estate, Construction & Property, HOPE, LMI, Partnership, SFR, Promise, Senior, Strategy, Empowerment, Investment, Renewable energy

The Promise Homes Company, one of the largest minority-led managers of institutional-quality, single-family residential rental homes in the United States, announced today that it has closed on a revolving credit facility from a leading global money-center bank.

Key Points: 
  • The Promise Homes Company, one of the largest minority-led managers of institutional-quality, single-family residential rental homes in the United States, announced today that it has closed on a revolving credit facility from a leading global money-center bank.
  • The facility will refinance Promise Homes’ SFR portfolio of approximately 630 homes and will provide additional capital for the company to pursue its growth strategy.
  • The facility includes attractive terms to support the Promise Homes mission.
  • All Promise Homes residents who have enrolled in financial or credit counseling through Operation HOPE have improved their credit scores within 90 days of beginning the program, and as a result, receive rent credits through Promise Homes’ incentive program.

Ten Community-Based Collaboratives Recognized as Exemplars in Education with Grants from Carnegie Corporation of New York

Retrieved on: 
Tuesday, March 26, 2024
Manufacturing, Other Philanthropy, State, Local, Public Policy, Labor, Foundation, Philanthropy, Government, General Health, Other Manufacturing, Health, Other Education, Healthcare Reform, Continuing, University, Primary, Secondary, Training, Education, West, Employment, Democracy, Indiana University Health, HOPE, Environment, Capstone, Communication, Intelligence, Partnership, Social mobility, Corporation, Mental health, Politics, Transport, Hope, Local government, Poverty, Student, Commerce, Creativity, CEN, Workforce, Multimedia, Nursing

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    Profiles in Collective Leadership provides $200,000 grants for nonpartisan collaborations that serve as education and economic bridges in a range of communities across the country.
  • The collaboratives draw on the strengths of local government, education, nonprofit, business, and health care professionals to create career opportunities for young people and encourage civic participation.
  • The 10 recognized partnerships in 8 states will act as exemplars, sharing what they have learned with each other and with the public.
  • “At Carnegie Corporation of New York, we are gravely concerned by the growing polarization of American politics and society,” said Dame Louise Richardson , president of the philanthropic foundation.

Cognito Therapeutics Announces Spectris™ OVERTURE OLE Study Data Supports Potential Disease Modification and Early Treatment in Alzheimer’s Disease

Retrieved on: 
Monday, March 11, 2024
Software, Research, Hardware, Pharmaceutical, Data Management, Technology, Medical Devices, Clinical Trials, Science, Neurology, Biotechnology, Health, Other Science, Cognito, Conference, MRI, HOPE, Parkinson's disease, Disease, Patient, Amyloid-related imaging abnormalities, OLE, ARIA, Clinical trial, Therapy, Safety, WBV, Pharmaceutical industry

The results support for Spectris’™ potential as a disease modifying therapy that, if approved, could also be used as an early intervention for the treatment of Alzheimer’s Disease (AD).

Key Points: 
  • The results support for Spectris’™ potential as a disease modifying therapy that, if approved, could also be used as an early intervention for the treatment of Alzheimer’s Disease (AD).
  • These results provide support for the potential safety of prolonged treatment and highlight the potential for Spectris as a potential disease modifying therapy to preserve both brain structure and function in patients with AD,” said Brent Vaughan, CEO of Cognito Therapeutics.
  • 83% of the OVERTURE study patients (44/53) entered a separate 12-month open label extension (OLE) study, which allowed for further evaluation of Spectris’ potential as a disease modifying therapy.
  • “These results are consistent with accepted criteria for disease modification and support potential for use as early treatment of AD.

Nintendo Celebrates MAR10 Day With Games, Movie News and a Variety of Mario-Themed Activities

Retrieved on: 
Monday, March 11, 2024
Toys, Entertainment, Retail, Other Entertainment, Film & Motion Pictures, Electronic Games, Online, Dark, Dark Moon, Maker, Cloud, Piranha Plant, Mario Kart 8, RPG, Super Mario, Friends, Paper, Smartphone, Target, Grand Champion, Nintendo eShop, HOPE, Amazon, Capsule, Golf, Lego Super Mario, GameCube, Purchasing, Internet, Mario Tennis, Game Boy, Travel, Virus, Super Mario Bros., Dark moon, Nintendo Switch Lite, Nintendo Switch, News, Fun, GameStop, Nintendo Switch Online, MAR10, Club, Nintendo Account, LEGO, Model, Multimedia, HD, Family, Super Mario Party, Tennis, Human, Video game

View the full release here: https://www.businesswire.com/news/home/20240311148081/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240311148081/en/
    Paper Mario: The Thousand-Year Door arrives on the Nintendo Switch family of systems on May 23.
  • The witty and whimsical RPG arrives on the Nintendo Switch system twenty years after its original debut on Nintendo GameCube.
  • * In honor of MAR10 Day, Nintendo is offering twice the fun with the Nintendo Switch Online 14-Day Free Trial Membership (typically 7 days), available now through March 17 on My Nintendo .
  • Watch the Super Mario Bros. Movie and Check Out the Companion Digital Guidebook – What better way to celebrate MAR10 Day than to watch The Super Mario Bros. Movie?